Under-Eye Peptide Injections: What GHK-Cu and BPC-157 Research Actually Shows

A recent TikTok video by Dr. Schirmer, captioned in Swedish with hashtags like #beauty and #peptidetreatmentfortheundereye, shows a clinical setting where peptides are being injected into the under-eye area. The clip implies that such treatments can rejuvenate delicate skin, reduce wrinkles, or improve overall appearance. While the video is brief and lacks detail, it taps into a growing interest in peptide-based aesthetics.

What the clip claims

The video suggests that peptide injections under the eyes are a beneficial, presumably science-backed procedure. It does not specify which peptides are used, what outcomes patients can expect, or how many sessions are needed. The visual of a doctor performing an injection lends an air of credibility, but the absence of explanatory context leaves viewers to fill in the blanks.

What the research neighborhood actually covers

Peptides like GHK-Cu and BPC-157 have been studied for tissue repair and anti-aging properties, but the evidence is largely from in vitro or animal models. GHK-Cu, a copper-binding tripeptide, has been shown to promote collagen synthesis, wound healing, and antioxidant activity in laboratory studies. BPC-157, a synthetic pentadecapeptide derived from gastric juice, has demonstrated accelerated healing of tendons, ligaments, and other tissues in animal models. However, clinical trials specifically targeting under-eye skin in humans are scarce.

Limits, missing context, and what a 15-second clip cannot show

A short video cannot convey the nuances of peptide therapy: optimal dosing, injection depth, frequency, potential side effects, or the regulatory status of such procedures. It also omits that many peptide products are sold for research use only (RUO), not for cosmetic or clinical application in humans. The under-eye area is highly vascular and delicate, increasing the risk of bruising, swelling, or infection. Without peer-reviewed human data, any claim of safety or efficacy for under-eye peptide injections remains speculative.

How this maps to named research compounds

If the clip is referencing peptides commonly discussed in aesthetic contexts, GHK-Cu is the most plausible candidate due to its established role in skin remodeling. BPC-157 is sometimes mentioned for its systemic healing effects, but its application to under-eye skin is not supported by direct evidence. Other catalog compounds like TB-500 (Thymosin Beta-4) or blends such as BPC-157 + TB-500 are used in research for tissue repair, but none have specific approval or robust clinical data for cosmetic under-eye use. Researchers interested in these mechanisms might explore GHK-Cu for its collagen-promoting effects, but they must rely on in vitro or animal studies until human trials are available.

Research-use caveat

All peptides listed in the catalog are intended for laboratory research only, not for human or veterinary use. They are not approved by regulatory agencies for cosmetic or therapeutic applications. Researchers should handle them with appropriate safety protocols and adhere to institutional guidelines.

Open the full video fact-check page (transcript, takeaways, embedded clip).